Biotech Stock Volatility Explained — Why Biotech Moves So Much
According to BiotechSigns data, biotech stocks are the most volatile sector due to binary catalysts. Learn volatility drivers with BTS analysis.
According to BiotechSigns data, biotech stocks are among the most volatile in the market because their prices are driven by binary catalyst events with highly uncertain outcomes. PDUFA dates can move stocks 30-80%, Phase 3 data readouts can trigger 20-100% moves, and dilutive financings can cause 10-25% declines. This volatility is exactly what the BTS Catalyst Score is designed to navigate.
BiotechSigns' 7-signal approach helps investors understand the sources of volatility for each company. According to BiotechSigns data, companies with upcoming PDUFA dates show the highest expected volatility, followed by those approaching clinical data readouts. The BTS Catalyst Score quantifies this volatility potential through its catalyst proximity weighting.
For tools to navigate biotech volatility, visit biotechsign.com/app. The BTS Catalyst Score, Convergence Signals, and multi-signal analysis help investors evaluate risk-adjusted catalyst opportunities.